Shibutani Hiroshi Chris

Shibutani Hiroshi Chris is listed in filings as EVP at Bristol-Myers Squibb Co. This profile follows SEC Form 4 activity through Mar 12, 2026, including 3 public disclosures. Recent filings connect the profile to Bristol-Myers Squibb Co (BMY). The current snapshot covers public activity from Jul 2, 2025 to Mar 12, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.